The neuroprotective effects of GDNF on various neurons suggested that it could be a good therapeutic candidate for neurodegenerative diseases including Parkinson’s disease and Alzheimer’s disease [72,73,74]. This evidence concerns the gene GDNF and early-onset autosomal dominant Alzheimer disease.